Drugs company Sequella and the University of Maryland in Baltimore are
patenting a system to help fight tuberculosis (W0 00/37114). The WHO warns that
TB bacteria are becoming resistant to antibiotics because patients do not finish
the course of treatment. The new process mixes the drug with a fluorescent
dye—fluorescein, indocyanin green or rhodamine. This causes a slight
fluorescence when the skin is illuminated. Patients wear a bracelet which shines
light at the skin. A sensor signals “OK� on a small display if it detects
fluorescence. Doctors only have to glance at it to know if a patient has taken
the drug.
More from New Ä¢¹½Ö±²¥
Explore the latest news, articles and features
Technology
The real reasons we keep seeing big tech outages – it isn’t just hackers
News
Technology
Quantum trick lets you share your location super securely
News
Technology
Laser weapons have come of age and are making their way to the battlefield
News
Space
We now know how radiation destroys electronics devices
News
Popular articles
Trending New Ä¢¹½Ö±²¥ articles